E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 6/21/2012 in the Prospect News PIPE Daily.

Accentia Biopharmaceuticals seals $225,000 private placement of units

Units sold at $0.21 each with five-year warrants exercisable at $0.28

By Devika Patel

Knoxville, Tenn., June 21 - Accentia Biopharmaceuticals, Inc. completed a $225,000 private placement of units on June 15, according to an 8-K filed Thursday with the Securities and Exchange Commission.

The company sold 1,071,432 units of one common share and a half-share warrant at $0.21 per unit.

The whole warrants will be exercisable at $0.28 until June 15, 2017. The strike price is a 21.74% premium to the June 14 closing share price of $0.23.

Accentia is a biopharmaceutical company based in Tampa, Fla.

Issuer:Accentia Biopharmaceuticals, Inc.
Issue:Units of one common share and a half-share warrant
Amount:$225,000
Units:1,071,432
Price:$0.21
Warrants:One half-share warrant per unit
Warrant expiration:June 15, 2017
Warrant strike price:$0.28
Settlement date:June 15
Stock symbol:OTCBB: ABPI
Stock price:$0.23 at close June 14

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.